| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| BDMDBaird Medical Investment Holdings Limited | 45.91M | 1.25 | 2.55 | 17.74% | 33.62% | 33% | 0.53 | |
| IVFINVO Fertility, Inc. | 12.29M | 0.81 | -0.03 | 116.25% | -417.01% | -495.09% | 0.78 | |
| AEMDAethlon Medical, Inc. | 2.64M | 2.71 | -0.03 | -0.2% | 0.13 | |||
| HYPDHyperion DeFi, Inc. | 27.38M | 3.35 | -0.06 | 14.14% | -73.86% | -36.05% | ||
| NAOVNanoVibronix, Inc. | 1.59M | 1.46 | -0.11 | 12.05% | -133.04% | -8.41% | 0.19 | |
| ALURAllurion Technologies Inc. | 23.21M | 1.89 | -0.16 | -39.94% | -251.56% | |||
| RBOTVicarious Surgical Inc. | 18.48M | 2.86 | -0.27 | -380.42% | 0.30 | |||
| TELATELA Bio, Inc. | 44.09M | 0.99 | -0.74 | 18.56% | -50.61% | -25.05% | 1.51 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 11.69K | 50.9K | 282.14K | 494.38K | 1.48M | 1.04M | 4.16M | 822.2K | 3.02M | 6.53M |
| Revenue Growth % | -0.3% | 3.35% | 4.54% | 0.75% | 1.99% | -0.3% | 3.01% | -0.8% | 2.67% | 1.16% |
| Cost of Goods Sold | 7.81K | 15.09K | 51.95K | 90.37K | 139.67K | 88.76K | 145.05K | 850.77K | 1.93M | 3.66M |
| COGS % of Revenue | 0.67% | 0.3% | 0.18% | 0.18% | 0.09% | 0.09% | 0.03% | 1.03% | 0.64% | 0.56% |
| Gross Profit | 3.88K | 35.81K | 230.19K | 404.01K | 1.34M | 948.53K | 4.02M | -28.57K | 1.09M | 2.87M |
| Gross Margin % | 0.33% | 0.7% | 0.82% | 0.82% | 0.91% | 0.91% | 0.97% | -0.03% | 0.36% | 0.44% |
| Gross Profit Growth % | -0.56% | 8.23% | 5.43% | 0.76% | 2.32% | -0.29% | 3.23% | -1.01% | 39.01% | 1.65% |
| Operating Expenses | 598.95K | 2.15M | 870.61K | 3.04M | 3.13M | 6.46M | 9.23M | 10.6M | 7.65M | 11M |
| OpEx % of Revenue | 51.24% | 42.16% | 3.09% | 6.15% | 2.11% | 6.23% | 2.22% | 12.89% | 2.53% | 1.68% |
| Selling, General & Admin | 598.95K | 2.15M | 870.61K | 3.04M | 3.13M | 6.07M | 9.02M | 9.98M | 7.49M | 9.08M |
| SG&A % of Revenue | 51.24% | 42.16% | 3.09% | 6.15% | 2.11% | 5.85% | 2.17% | 12.13% | 2.48% | 1.39% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 398.43K | 216.43K | 544.04K | 165.94K | 489.66K |
| R&D % of Revenue | - | - | - | - | - | 0.38% | 0.05% | 0.66% | 0.05% | 0.07% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 77.3K | 200.89K | 1.43M |
| Operating Income | -595.07K | -2.11M | -640.42K | -2.63M | -1.79M | -5.51M | -5.22M | -10.63M | -6.77M | -8.13M |
| Operating Margin % | -50.91% | -41.46% | -2.27% | -5.33% | -1.21% | -5.32% | -1.25% | -12.92% | -2.24% | -1.24% |
| Operating Income Growth % | 0.65% | -2.55% | 0.7% | -3.11% | 0.32% | -2.08% | 0.05% | -1.04% | 0.36% | -0.2% |
| EBITDA | -589.44K | -2.11M | -637.61K | -2.63M | -1.76M | -5.48M | -5.05M | -10.55M | -6.57M | -7.21M |
| EBITDA Margin % | -50.43% | -41.42% | -2.26% | -5.32% | -1.19% | -5.28% | -1.21% | -12.83% | -2.17% | -1.1% |
| EBITDA Growth % | 0.65% | -2.58% | 0.7% | -3.12% | 0.33% | -2.11% | 0.08% | -1.09% | 0.38% | -0.1% |
| D&A (Non-Cash Add-back) | 5.63K | 1.88K | 2.81K | 5.19K | 25.35K | 34.48K | 166.08K | 77.3K | 200.89K | 919.6K |
| EBIT | -4.93M | -2.11M | -681.29K | -2.63M | -1.79M | -5.51M | -5.38M | -10.83M | -7.08M | -8.06M |
| Net Interest Income | -32.02K | -13.84K | -20.87K | -442.03K | -379.02K | -2.83M | -1.26M | -59.14K | -925.91K | -1.06M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 4.19K | 3.66K | 308 | 0 | 0 |
| Interest Expense | 32.02K | 13.84K | 20.87K | 442.03K | 379.02K | 2.84M | 1.27M | 59.45K | 925.91K | 1.06M |
| Other Income/Expense | -4.36M | -13.84K | -61.74K | -442.03K | -379.02K | -2.83M | -1.43M | -263.16K | -1.24M | -993.25K |
| Pretax Income | -4.96M | -2.12M | -702.16K | -3.08M | -2.17M | -8.35M | -6.65M | -10.89M | -8.01M | -9.12M |
| Pretax Margin % | -424.27% | -41.73% | -2.49% | -6.22% | -1.46% | -8.05% | -1.6% | -13.24% | -2.65% | -1.4% |
| Income Tax | 0 | 0 | 0 | 0 | 433 | 36 | 4.76K | 2.87K | 27.79K | -22.91K |
| Effective Tax Rate % | 1% | 1% | 1% | 1% | 1% | 1% | 1% | 1% | 1% | 1% |
| Net Income | -4.96M | -2.12M | -702.16K | -3.08M | -2.17M | -8.35M | -6.65M | -10.89M | -8.03M | -9.1M |
| Net Margin % | -424.27% | -41.73% | -2.49% | -6.22% | -1.46% | -8.05% | -1.6% | -13.25% | -2.66% | -1.39% |
| Net Income Growth % | -1.86% | 0.57% | 0.67% | -3.38% | 0.3% | -2.85% | 0.2% | -0.64% | 0.26% | -0.13% |
| Net Income (Continuing) | -4.96M | -2.12M | -702.16K | -3.08M | -2.17M | -8.35M | -6.65M | -10.89M | -8.03M | -9.1M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -12.80 | -6.40 | -1.59 | -6.68 | -4.46 | -15.21 | -6.26 | -8.99 | -5.13 | -30.19 |
| EPS Growth % | 0.92% | 0.5% | 0.75% | -3.2% | 0.33% | -2.41% | 0.59% | -0.44% | 0.43% | -4.88% |
| EPS (Basic) | -12.80 | -6.40 | -1.59 | -6.68 | -4.46 | -15.21 | -6.26 | -8.99 | -5.13 | -30.19 |
| Diluted Shares Outstanding | 803.54K | 869.91K | 883.16K | 920.83K | 970.97K | 1.1M | 2.13M | 2.42M | 3.13M | 309.54K |
| Basic Shares Outstanding | 803.54K | 869.91K | 883.16K | 920.83K | 970.97K | 1.1M | 2.13M | 2.42M | 3.13M | 309.54K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 558.77K | 251.39K | 234.38K | 731.11K | 1.54M | 10.54M | 6.31M | 621.09K | 1.26M | 1.32M |
| Cash & Short-Term Investments | 492K | 152.4K | 25.76K | 212.24K | 1.24M | 10.1M | 5.68M | 90.14K | 232.42K | 741.4K |
| Cash Only | 492K | 152.4K | 25.76K | 212.24K | 1.24M | 10.1M | 5.68M | 90.14K | 232.42K | 741.4K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 1.35K | 2.79K | 86.7K | 225.9K | 7.56K | 21.7K | 50.47K | 77.15K | 140.55K | 174.88K |
| Days Sales Outstanding | 42.03 | 20.04 | 112.16 | 166.78 | 1.86 | 7.64 | 4.43 | 34.25 | 16.98 | 9.77 |
| Inventory | 65.42K | 85.21K | 58.88K | 43.51K | 101.39K | 265.37K | 287.77K | 263.6K | 264.51K | 219.76K |
| Days Inventory Outstanding | 3.06K | 2.06K | 413.65 | 175.75 | 264.95 | 1.09K | 724.13 | 113.09 | 49.91 | 21.93 |
| Other Current Assets | 0 | 0 | 0 | 0 | 195.91K | 0 | 0 | 190.2K | 622.29K | 182.29K |
| Total Non-Current Assets | 21.02K | 34.84K | 32.03K | 46.24K | 252.04K | 404.81K | 4.16M | 3.09M | 17.25M | 45.13M |
| Property, Plant & Equipment | 0 | 15.7K | 15.7K | 34.45K | 194.94K | 211.53K | 2.54M | 1.85M | 4.19M | 2.75M |
| Fixed Asset Turnover | - | 3.24x | 17.97x | 14.35x | 7.59x | 4.90x | 1.64x | 0.44x | 0.72x | 2.37x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.88M | 23.54M |
| Intangible Assets | 21.02K | 19.14K | 16.33K | 11.79K | 57.1K | 94.96K | 132.09K | 0 | 4.09M | 18.1M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 98.08K | 1.49M | 1.24M | 3.09M | 740.76K |
| Other Non-Current Assets | 0 | 0 | 2 | 0 | 0 | 240 | 0 | 0 | 0 | 0 |
| Total Assets | 579.79K | 286.23K | 266.41K | 777.35K | 1.8M | 10.95M | 10.47M | 3.71M | 18.51M | 46.45M |
| Asset Turnover | 0.02x | 0.18x | 1.06x | 0.64x | 0.82x | 0.09x | 0.40x | 0.22x | 0.16x | 0.14x |
| Asset Growth % | 4.37% | -0.51% | -0.07% | 1.92% | 1.31% | 5.1% | -0.04% | -0.65% | 3.99% | 1.51% |
| Total Current Liabilities | 4.34M | 4.77M | 5.13M | 3.5M | 1.5M | 2.29M | 1.25M | 3.34M | 8M | 17.93M |
| Accounts Payable | 1.03M | 974.87K | 960.73K | 571.83K | 371.53K | 328.93K | 443.42K | 1.35M | 2.33M | 5.71M |
| Days Payables Outstanding | 47.93K | 23.57K | 6.75K | 2.31K | 970.92 | 1.35K | 1.12K | 578.77 | 439.71 | 570.18 |
| Short-Term Debt | 220.89K | 220.89K | 210.89K | 395.59K | 21.36K | 693.68K | 0 | 762.64K | 1.51M | 6.34M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 18.89K | 714.29K | 714.29K | 5.9K | 119.88K | 408.77K | 602.36K |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 0 | 527.33K | 581.69K | 946.26K | 1.07M | 2.53M |
| Current Ratio | 0.13x | 0.05x | 0.05x | 0.21x | 1.03x | 4.61x | 5.03x | 0.19x | 0.16x | 0.07x |
| Quick Ratio | 0.11x | 0.03x | 0.03x | 0.20x | 0.96x | 4.49x | 4.80x | 0.11x | 0.12x | 0.06x |
| Cash Conversion Cycle | -44.83K | -21.49K | -6.22K | -1.97K | -704.1 | -253.72 | -387.24 | -431.43 | -372.82 | -538.48 |
| Total Non-Current Liabilities | 0 | 131.72K | 131.72K | 0 | 4.01M | 2.92M | 1.9M | 1.35M | 9.61M | 15.78M |
| Long-Term Debt | 0 | 131.72K | 131.72K | 0 | 354.61K | 0 | 0 | 0 | 1.25M | 1.13M |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 81.49K | 58.63K | 1.9M | 1.35M | 3.36M | 2.19M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 433 | 469 | 1.14K | 1.95K | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5M | 12.46M |
| Total Liabilities | 4.34M | 4.9M | 5.26M | 3.5M | 5.51M | 5.2M | 3.16M | 4.69M | 17.61M | 33.7M |
| Total Debt | 220.89K | 352.61K | 342.61K | 395.59K | 457.47K | 775.02K | 2.12M | 2.27M | 6.3M | 9.9M |
| Net Debt | -271.12K | 200.21K | 316.85K | 183.35K | -781.12K | -9.32M | -3.56M | 2.18M | 6.07M | 9.15M |
| Debt / Equity | - | - | - | - | - | 0.13x | 0.29x | - | 7.06x | 0.78x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -18.59x | -152.51x | -30.68x | -5.96x | -4.72x | -1.94x | -4.12x | -178.76x | -7.31x | -7.69x |
| Total Equity | -3.76M | -4.62M | -4.99M | -2.72M | -3.71M | 5.74M | 7.31M | -977.61K | 892.83K | 12.75M |
| Equity Growth % | 0.14% | -0.23% | -0.08% | 0.45% | -0.36% | 2.55% | 0.27% | -1.13% | 1.91% | 13.28% |
| Book Value per Share | -4.68 | -5.31 | -5.65 | -2.96 | -3.82 | 5.23 | 3.44 | -0.40 | 0.29 | 41.18 |
| Total Shareholders' Equity | -3.76M | -4.62M | -4.99M | -2.72M | -3.71M | 5.74M | 7.31M | -977.61K | 892.83K | 12.75M |
| Common Stock | 13.71K | 14.06K | 14.21K | 15.43K | 15.63K | 964 | 1.19K | 61 | 249 | 37 |
| Retained Earnings | -15.82M | -17.94M | -18.65M | -21.72M | -23.89M | -32.24M | -38.89M | -49.78M | -57.82M | -67.16M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -151.62K | -323.9K | -181.27K | -652.97K | 1.37M | -4.78M | -6.03M | -6.6M | -4.76M | -2.97M |
| Operating CF Margin % | -12.97% | -6.36% | -0.64% | -1.32% | 0.93% | -4.6% | -1.45% | -8.03% | -1.57% | -0.46% |
| Operating CF Growth % | -6.82% | -1.14% | 0.44% | -2.6% | 3.1% | -4.48% | -0.26% | -0.1% | 0.28% | 0.37% |
| Net Income | -4.96M | -2.12M | -702.16K | -3.08M | -2.17M | -8.35M | -6.65M | -10.89M | -8.03M | -9.1M |
| Depreciation & Amortization | 5.63K | 1.88K | 2.81K | 5.19K | 25.35K | 34.48K | 166.08K | 77.3K | 200.89K | 919.6K |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 1.76M | 2.71M | 2.22M | 1.39M | 1.59M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 433 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 4.42M | 1.26M | 256K | 2.46M | 564.7K | 2.63M | 1.36M | 505.43K | 1.21M | 1.75M |
| Working Capital Changes | 378.52K | 534.87K | 262.08K | -40.86K | 2.95M | -845.52K | -3.61M | 1.48M | 471.7K | 1.86M |
| Change in Receivables | -1.02K | -1.45K | -83.9K | -139.2K | 218.34K | -14.14K | -28.77K | -26.68K | 0 | -34.33K |
| Change in Inventory | -2.96K | -19.79K | 26.33K | 15.37K | -57.87K | -163.99K | -22.4K | 24.17K | 0 | 44.74K |
| Change in Payables | -6.29K | 82.81K | -5.35K | -377.81K | -200.3K | -42.6K | 114.5K | 904.06K | 924.68K | 1.35M |
| Cash from Investing | 0 | -15.7K | 0 | -19.4K | -114.71K | -187.25K | -2.15M | -81.22K | -2.49M | 363.89K |
| Capital Expenditures | 0 | -15.7K | 0 | -19.4K | -114.71K | -49.26K | -415.71K | -10.79K | -444.72K | -183.7K |
| CapEx % of Revenue | 0% | 0.31% | - | 0.04% | 0.08% | 0.05% | 0.1% | 0.01% | 0.15% | 0.03% |
| Acquisitions | - | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | -39.91K | -38.94K | -1.94K | 0 | 75.59K |
| Cash from Financing | 625K | 0 | 54.63K | 858.86K | -229.47K | 13.82M | 3.77M | 1.09M | 7.39M | 3.12M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - | - | - |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 369.84K | 0 | 0 | 900.61K |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | -151.62K | -339.6K | -181.27K | -672.37K | 1.31M | -4.86M | -6.48M | -6.62M | -5.2M | -3.16M |
| FCF Margin % | -12.97% | -6.67% | -0.64% | -1.36% | 0.88% | -4.69% | -1.56% | -8.05% | -1.72% | -0.48% |
| FCF Growth % | -6.82% | -1.24% | 0.47% | -2.71% | 2.94% | -4.73% | -0.33% | -0.02% | 0.21% | 0.39% |
| FCF per Share | -0.19 | -0.39 | -0.21 | -0.73 | 1.34 | -4.43 | -3.05 | -2.73 | -1.66 | -10.20 |
| FCF Conversion (FCF/Net Income) | 0.03x | 0.15x | 0.26x | 0.21x | -0.63x | 0.57x | 0.91x | 0.61x | 0.59x | 0.33x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 253.39K | 52.6K | 0 | 9.64K | 214.74K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 1.06K | 3.31K | 800 | 0 | 0 |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | - | - | - | -822.59% | -101.96% | -343.99% | -899.91% | -133.37% |
| Return on Invested Capital (ROIC) | - | - | - | - | - | - | -4610.16% | -321.89% | -124.33% | -42.23% |
| Gross Margin | 33.18% | 70.35% | 81.59% | 81.72% | 90.56% | 91.44% | 96.51% | -3.48% | 35.96% | 44% |
| Net Margin | -42426.61% | -4173.3% | -248.87% | -622.22% | -146.43% | -804.73% | -159.97% | -1324.81% | -266% | -139.25% |
| Debt / Equity | - | - | - | - | - | 0.13x | 0.29x | - | 7.06x | 0.78x |
| Interest Coverage | -18.59x | -152.51x | -30.68x | -5.96x | -4.72x | -1.94x | -4.12x | -178.76x | -7.31x | -7.69x |
| FCF Conversion | 0.03x | 0.15x | 0.26x | 0.21x | -0.63x | 0.57x | 0.91x | 0.61x | 0.59x | 0.33x |
| Revenue Growth | -29.53% | 335.46% | 454.3% | 75.22% | 199.41% | -29.92% | 301.06% | -80.24% | 267.38% | 116.25% |
INVO Fertility, Inc. (IVF) reported $6.9M in revenue for fiscal year 2024. This represents a 9611% increase from $0.1M in 2011.
INVO Fertility, Inc. (IVF) grew revenue by 116.3% over the past year. This is strong growth.
INVO Fertility, Inc. (IVF) reported a net loss of $29.0M for fiscal year 2024.
INVO Fertility, Inc. (IVF) has a return on equity (ROE) of -133.4%. Negative ROE indicates the company is unprofitable.
INVO Fertility, Inc. (IVF) had negative free cash flow of $7.8M in fiscal year 2024, likely due to heavy capital investments.